Medgenics: Corporate Presentation (Medgenics) - Nov 28, 2014 - Anticipated initiation of P2 trial in anemic CKD transplant in H1 2015; Anticipated initiation of P2 trial in peritoneal dialysis in H1 2015; Anticipated initiation of P2 trial in MDS in H2 2015; Anticipated interim data from small signal finding studies in renal anemia - ESRD in H2 2015; Anticipated submission of IND for hematological disorders in H1 2015; Anticipated interim data from small signal finding studies in hematological disorders in H2 2015/H1 2016; Anticipated interim data from small signal finding studies in beta thalassemia in H2 2015
Anticipated clinical data • Anticipated IND • Anticipated new P2 trial • Biosimilar
|